Showing results (461-470 of 507) with videos related to

Sort By:
Pageof 51
Frontiers in Cell and Developmental Biology|August 5, 2022
High enhancer activity is an epigenetic feature of HPV negative atypical head and neck squamous cell carcinomaS Carson Callahan, Veena Kochat, Zhiyi Liu, et al.
Frontiers in Oncology|January 23, 2023
Separate and combined effects of advanced age and obesity on mammary adipose inflammation, immunosuppression and tumor progression in mouse models of triple negative breast cancerLaura A Smith, Dalton M Craven, Magdalena A Rainey, et al.
American Journal of Respiratory and Critical Care Medicine|March 26, 2010
An official American Thoracic Society policy statement: pay-for-performance in pulmonary, critical care, and sleep medicineJeremy M Kahn, Damon C Scales, David H Au, et al.
Plos One|October 18, 2017
Premature aortic smooth muscle cell differentiation contributes to matrix dysregulation in Marfan SyndromeMatthew Dale, Matthew P Fitzgerald, Zhibo Liu, et al.
Plos One|July 17, 2018
Correction: Premature aortic smooth muscle cell differentiation contributes to matrix dysregulation in Marfan SyndromeMatthew Dale, Matthew P Fitzgerald, Zhibo Liu, et al.
The EMBO Journal|October 15, 1996
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalitiesS R McKercher, B E Torbett, K L Anderson, et al.
American Journal of Respiratory and Critical Care Medicine|September 6, 2014
Multicenter study comparing case definitions used to identify patients with chronic obstructive pulmonary diseaseValentin Prieto-Centurion, Andrew J Rolle, David H Au, et al.
Critical Care Medicine|January 23, 2010
Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trialTimothy D Girard, Pratik P Pandharipande, Shannon S Carson, et al.
Healthcare (Amsterdam, Netherlands)|October 9, 2021
Rapid analysis of local data to inform off-label tocilizumab use early in the COVID-19 pandemicCamille E Morgan, Casey A Rimland, Griffin J Bell, et al.
Science Translational Medicine|May 3, 2019
A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autismKaren J Parker, Ozge Oztan, Robin A Libove, et al.
Pageof 51